Particle.news

Brazil Cracks Down on Illicit Mounjaro Sales as Lilly Launches QR Verification Tool

New verification reflects mounting safety risks from counterfeit tirzepatide circulating outside Brazil’s regulated supply.

Overview

  • São Paulo Civil Police arrested a woman in the Jacuba district of Arealva on suspicion of storing and selling Mounjaro without sanitary authorization.
  • Officers seized five boxes of Mounjaro, two boxes of syringes, expired weight‑loss products, and a cellphone allegedly used for transactions.
  • Eli Lilly introduced LillyScan, an online checker that scans the packaging QR code to verify whether a product’s serial number matches items manufactured by the company and sold officially in Brazil.
  • The company reports falsified and manipulated versions of Mounjaro or tirzepatide are being advertised nationwide, posing risks such as incorrect dosing, lack of active ingredient, or contamination.
  • Lilly states its Mounjaro is the only tirzepatide approved by Anvisa and advises purchasing only from Anvisa‑licensed pharmacies under medical prescription.